Mettler Toledo, stylized in all caps, is a multinational supplier of precision instruments and services. The company focuses on laboratory, industrial, product inspection, and food retailing applications. Its products are used in research, quality control, and manufacturing processes in life sciences, food, chemical, and many other industries. The company's business is geographically diversified, with sales in 2023 derived 41% from North and South America, 27% from Europe, and 32% from Asia and other countries. The company’s global workforce consists of 17,300 employees as of December 31, 2023.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| MTD | METTLER TOLEDO INTERNATIONAL INC/ | 2026-02-17 17:02:23 | 1,353.24 | 0 | 0 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MTD | 0001037646 | METTLER TOLEDO INTERNATIONAL INC/ | US5926881054 | 5493000BD5GJNUDIUG10 | 133668641 | NYSE | 3826 | Laboratory Analytical Instruments | 1231 | DE | 1900 POLARIS PARKWAY | COLUMBUS | OH | 43240 | UNITED STATES | US | 6144384511 | 1900 POLARIS PARKWAY, COLUMBUS, OH, 43240 | 1900 POLARIS PARKWAY, COLUMBUS, OH, 43240 | MT INVESTORS INC/ | Scientific instruments | 1945 | Patrick Kaltenbach | 17,300 | http://mt.com | 24,200,000,000 | 44,786,011 | 20,325,250 | Mettler Toledo, stylized in all caps, is a multinational supplier of precision instruments and services. The company focuses on laboratory, industrial, product inspection, and food retailing applications. Its products are used in research, quality control, and manufacturing processes in life sciences, food, chemical, and many other industries. The company's business is geographically diversified, with sales in 2023 derived 41% from North and South America, 27% from Europe, and 32% from Asia and other countries. The company’s global workforce consists of 17,300 employees as of December 31, 2023. | 2026-02-12 15:38:15 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 24,200,000,000 | -5,500,000,000 | -18.5185 | 20,325,250 | -591,209 | -2.8265 |
| 2024 | 29,700,000,000 | 1,000,000,000 | 3.4843 | 20,916,459 | -562,246 | -2.6177 |
| 2023 | 28,700,000,000 | 2,800,000,000 | 10.8108 | 21,478,705 | -627,470 | -2.8384 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Patrick Kaltenbach | Chief Executive Officer, President | 2024 | 1,062,138 | — | 1,526,729 | 764,739 | 408,511 | 6,817,569 |
| Shawn P. Vadala | Chief Financial Officer | 2024 | 457,500 | — | 504,294 | 306,176 | 25,525 | 2,302,907 |
| Shawn P. Vadala | Chief Financial Officer | 2023 | 450,000 | — | 485,421 | 93,375 | 27,900 | 2,027,068 |
| Patrick Kaltenbach | Chief Executive Officer, President | 2023 | 1,001,001 | — | 2,468,360 | 155,155 | 355,864 | 8,417,336 |
| Patrick Kaltenbach | President | 2022 | 890,426 | — | 1,414,265 | 670,045 | 422,290 | 6,223,115 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 9,300 |
| 2024 | 9,000 |
| 2023 | 9,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 4,026,399,000 | 3,872,361,000 | 3,788,309,000 |
| Cost Of Revenue | 1,170,864,000 | 1,110,886,000 | 1,144,167,000 |
| Gross Profit | 2,390,646,000 | 2,325,583,000 | 2,241,286,000 |
| Research And Development Expenses | 199,373,000 | 189,357,000 | 185,284,000 |
| General And Administrative Expenses | 998,314,000 | 936,303,000 | 904,106,000 |
| Operating Expenses | — | — | — |
| Operating Income | — | — | — |
| Net Income | 869,193,000 | 863,140,000 | 788,778,000 |
| Earnings Per Share Basic | 42.17 | 40.67 | 36.1 |
| Earnings Per Share Diluted | 42.05 | 40.48 | 35.9 |
| Weighted Average Shares Outstanding Basic | 20,610,189 | 21,221,839 | 21,848,122 |
| Weighted Average Shares Outstanding Diluted | 20,671,708 | 21,320,641 | 21,971,528 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 66,888,000 | 59,362,000 | 69,807,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 778,243,000 | 687,112,000 | 663,893,000 |
| Inventories | 387,228,000 | 342,274,000 | 385,865,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 1,362,667,000 | 1,193,906,000 | 1,230,203,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 845,636,000 | 770,280,000 | 803,374,000 |
| Other Assets Non Current | 444,828,000 | 315,170,000 | 335,242,000 |
| Total Assets Non Current | 2,349,979,000 | 2,046,093,000 | 2,125,352,000 |
| Total Assets | 3,712,646,000 | 3,239,999,000 | 3,355,555,000 |
| Accounts Payable | 266,628,000 | 215,843,000 | 210,411,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 63,931,000 | 182,623,000 | 192,219,000 |
| Other Liabilities Current | 237,482,000 | 187,701,000 | 196,138,000 |
| Total Liabilities Current | 1,198,116,000 | 1,168,193,000 | 1,181,082,000 |
| Long Term Debt | 2,088,241,000 | 1,831,265,000 | 1,888,620,000 |
| Other Liabilities Non Current | 298,141,000 | 263,478,000 | 327,112,000 |
| Total Liabilities Non Current | 2,538,166,000 | 2,198,696,000 | 2,324,411,000 |
| Total Liabilities | 3,736,282,000 | 3,366,889,000 | 3,505,493,000 |
| Common Stock | 448,000 | 448,000 | 448,000 |
| Retained Earnings | 9,238,196,000 | 8,371,420,000 | 7,510,756,000 |
| Accumulated Other Comprehensive Income | -359,157,000 | -345,858,000 | -319,815,000 |
| Total Shareholders Equity | -23,636,000 | -126,890,000 | -149,938,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 51,141,000 | 50,352,000 | 48,951,000 |
| Share Based Compensation Expense | 22,512,000 | 19,979,000 | 17,928,000 |
| Other Non Cash Income Expense | 13,685,000 | 22,982,000 | 0 |
| Change In Accounts Receivable | 46,349,000 | 52,999,000 | -50,296,000 |
| Change In Inventories | 7,651,000 | -24,127,000 | -71,021,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | 10,847,000 | 1,015,000 | -20,666,000 |
| Change In Accounts Payable | 33,762,000 | 12,083,000 | -40,554,000 |
| Change In Other Liabilities | -15,428,000 | 19,939,000 | -62,312,000 |
| Cash From Operating Activities | 955,772,000 | 968,346,000 | 965,874,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 107,124,000 | 103,898,000 | 105,323,000 |
| Acquisition Of Business | 93,839,000 | 10,091,000 | 5,811,000 |
| Other Investing Activities | -919,000 | 7,104,000 | 27,489,000 |
| Cash From Investing Activities | -193,874,000 | -119,462,000 | -131,694,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 799,995,000 | 849,997,000 | 900,000,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | -1,161,000 | -2,884,000 | -826,000 |
| Cash From Financing Activities | -755,173,000 | -855,977,000 | -859,585,000 |
| Change In Cash | 7,526,000 | -10,445,000 | -26,159,000 |
| Cash At End Of Period | 66,888,000 | 59,362,000 | 69,807,000 |
| Income Taxes Paid | 180,848,000 | 209,374,000 | 178,255,000 |
| Interest Paid | 66,634,000 | 75,937,000 | 75,618,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 42.17 | 40.67 | 36.1 |
| Price To Earnings Ratio | 33.0612 | 30.088 | 33.6 |
| Earnings Growth Rate | 3.6882 | 12.6593 | -6.9348 |
| Price Earnings To Growth Ratio | 8.964 | 2.3768 | -4.8451 |
| Book Value Per Share | -1.1468 | -5.9792 | -6.8627 |
| Price To Book Ratio | -1,215.7099 | -204.6555 | -176.7457 |
| Ebitda | 1,169,697,000 | 1,197,497,000 | 1,093,350,000 |
| Enterprise Value | 30,819,803,401.91 | 27,923,265,947.52 | 28,511,930,061.12 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | -91.0548 | -15.8711 | -13.878 |
| Capital Expenditures | 126,497,000 | 17,258,000 | 73,725,000 |
| Free Cash Flow | 829,275,000 | 951,088,000 | 892,149,000 |
| Return On Equity | -36.7741 | -6.8023 | -5.2607 |
| One Year Beta | 1.1093 | 1.0585 | 1.0213 |
| Three Year Beta | 1.0722 | 1.1465 | 1.1435 |
| Five Year Beta | 1.1233 | 1.006 | 1.0274 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Vadala Shawn | Chief Financial Officer | 2026-02-10 | 800 | A | 6,088 |
| Vadala Shawn | Chief Financial Officer | 2026-02-10 | 800 | D | 5,288 |
| Vadala Shawn | Chief Financial Officer | 2026-02-10 | 800 | D | 2,240 |
| Vadala Shawn | Chief Financial Officer | 2025-11-25 | 1,000 | A | 6,288 |
| Vadala Shawn | Chief Financial Officer | 2025-11-25 | 1,000 | D | 5,288 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Thomas H Tuberville | Senator | 2023-05-12 | Sale (Full) | 2023-04-03 | Joint | $1,001 - $15,000 |
| Thomas H Tuberville | Senator | 2023-05-11 | Sale (Full) | 2023-04-03 | Joint | $1,001 - $15,000 |
| Susan M Collins | Senator | 2017-05-10 | Purchase | 2016-12-01 | Spouse | $1,001 - $15,000 |
| Susan M Collins | Senator | 2017-01-10 | Purchase | 2016-12-01 | Spouse | $1,001 - $15,000 |
| Susan M Collins | Senator | 2015-01-29 | Purchase | 2015-01-13 | Spouse | $15,001 - $50,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Julia Letlow | 2026-01-13 | LA05 | Purchase | 2025-07-25 | — | $1,001 - $15,000 |
| Julia Letlow | 2026-01-13 | LA05 | Purchase | 2024-12-18 | — | $1,001 - $15,000 |
| Julia Letlow | 2026-01-13 | LA05 | Sale | 2025-12-08 | — | $1,001 - $15,000 |
| Rob Bresnahan | 2025-05-31 | PA08 | Purchase | 2025-05-15 | — | $1,001 - $15,000 |
| Julie Johnson | 2025-05-14 | TX32 | Sale | 2025-04-01 | Joint | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| CANADA PENSION PLAN INVESTMENT BOARD | 2025-12-31 | 7,334,834 | 5,261 | 1,394.1901 |
| Bellevue Group AG | 2025-12-31 | 52,979 | 38 | 1,394.1842 |
| Redwood Investment Management, LLC | 2025-12-31 | 1,096,000 | 786 | 1,394.402 |
| Cresset Asset Management, LLC | 2025-12-31 | 437,776 | 314 | 1,394.1911 |
| Select Equity Group, L.P. | 2025-12-31 | 34,386,302 | 24,664 | 1,394.19 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Value Line Mid Cap Focused Fund, Inc. | 2025-12-31 | Institutional Class | VLMIX | 14,100 | 19,658,079 | 1.1913 |
| Value Line Mid Cap Focused Fund, Inc. | 2025-12-31 | VALUE LINE MID CAP FOCUSED FUND, INC. | VLIFX | 14,100 | 19,658,079 | 1.1913 |
| EMPOWER FUNDS, INC. | 2025-12-31 | Institutional Class | MXYKX | 26,400 | 36,806,615.69 | 1.8296 |
| EMPOWER FUNDS, INC. | 2025-12-31 | Investor Class | MXMGX | 26,400 | 36,806,615.69 | 1.8296 |
| EMPOWER FUNDS, INC. | 2025-12-31 | Institutional Class | MXKWX | 3,447 | 4,805,772.97 | 0.052 |